A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.
about
A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A phase I clinical study to ev ...... urium for canine osteosarcoma.
@en
A phase I clinical study to ev ...... urium for canine osteosarcoma.
@nl
type
label
A phase I clinical study to ev ...... urium for canine osteosarcoma.
@en
A phase I clinical study to ev ...... urium for canine osteosarcoma.
@nl
prefLabel
A phase I clinical study to ev ...... urium for canine osteosarcoma.
@en
A phase I clinical study to ev ...... urium for canine osteosarcoma.
@nl
P2093
P2860
P356
P1476
A phase I clinical study to ev ...... murium for canine osteosarcoma
@en
P2093
Amber L Winter
Antonella Borgatti
Daniel A Saltzman
Emily Greengard
Kathleen M Stuebner
Lance B Augustin
Michael S Henson
Sara E Fritz
Vicki L Wilk
P2860
P304
P356
10.1002/VMS3.32
P577
2016-06-06T00:00:00Z